Clinical Trials Logo

Panic Disorder clinical trials

View clinical trials related to Panic Disorder.

Filter by:

NCT ID: NCT03061448 Completed - Clinical trials for Panic Disorder With Agoraphobia

Internet-based Exposure Therapy for Panic Disorder

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is examine if an internet-based exposure therapy based on inhibitory learning is feasible, acceptable and effective in reducing panic symptoms amongst patients who suffer from panic disorder and agoraphobia.

NCT ID: NCT03051074 Completed - Clinical trials for Major Depressive Disorder

Examining the Effects of Reduced Environmental Stimulation on Anxiety

Start date: December 1, 2016
Phase: N/A
Study type: Interventional

The studies proposed in this protocol aim to explore the anxiolytic properties of floating as it relates to the central and autonomic nervous system.

NCT ID: NCT03015285 Not yet recruiting - Major Depression Clinical Trials

CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT

Start date: January 2017
Phase: N/A
Study type: Interventional

Adults with high anxiety sensitivity (AS) and a mental health diagnosis of anxiety, depression, or posttraumatic stress will be recruited and will be randomly assigned to either transdiagnostic cognitive behavioural therapy (CBT) for AS or disorder-specific CBT for their primary mental health problem. The study outcomes - AS, anxiety, mood, and substance use symptoms, and functional impairment - will be assessed at pre-and post-treatment and 6 and 12 months post-treatment via standardized self-report measures completed by participants and a standardized diagnostic interview.

NCT ID: NCT02998502 Completed - Anxiety Clinical Trials

The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens

Start date: September 2016
Phase: N/A
Study type: Interventional

This study will test the efficiency of the Freespira Breathing System in youth.

NCT ID: NCT02954731 Completed - Panic Disorder Clinical Trials

Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder

TRACT-RCT
Start date: December 2016
Phase: N/A
Study type: Interventional

Transdiagnostic Cognitive Behavior Therapy (CBT) delivered in the individual format, have been proven just as effective as traditional diagnosis specific CBT manuals. The investigators have translated and modified the "The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP-CBT) to make it applicable as group therapy in Danish Mental Health Service and a naturalistic trial of this manual has shown promising results. As the use of one manual instead of several diagnosis specific manuals in regional clinics could simplify logistics and reduce waiting time, the investigators want to compare group UP-CBT with diagnosis specific group CBT. Method: A partial blinded, pragmatic, non-inferiority, multicentre randomized clinical trial (RCT). UP-CBT is compared to treatment-as-usual CT. 124 patients are included in each intervention arm, recruited from three Danish regional Mental Health Service Clinics. 31st July 2018 suppl: Inclusion number expanded to 170 in each arm due to unexpected large drop-out.

NCT ID: NCT02872051 Completed - Depression Clinical Trials

Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression

IBBIS
Start date: April 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy of 1) a stepped mental health care intervention and 2) an integrated mental health care and vocational rehabilitation intervention for people on sick leave because of depression and anxiety in Denmark

NCT ID: NCT02852577 Completed - Panic Disorder Clinical Trials

Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine

LTTPANIC
Start date: January 2000
Phase: Phase 4
Study type: Interventional

The purpose of this study was to determine whether clonazepam and paroxetine are effective in the treatment of panic disorder. Efficacy was evaluated in short-term, long-term and post-treatment.

NCT ID: NCT02826096 Completed - Panic Disorder Clinical Trials

A Brief Version of Biofeedback Therapy for Panic Disorder

Start date: December 21, 2015
Phase: N/A
Study type: Interventional

The study is to examine the therapeutic effect of a brief version of biofeedback therapy (developed bu the research team) on panic disorder. It is a randomized controlled design. The severity of panic symptoms of two groups of panic patients (reveiving biofeedback therapy or not) were measured before and after the six week duration. Besides, the severity of anxiety, depressive, somatic symptoms, and physiological indexes were recorded.

NCT ID: NCT02811458 Completed - Clinical trials for Generalized Anxiety Disorder

Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders

T-CBT
Start date: September 12, 2016
Phase: N/A
Study type: Interventional

Anxiety disorders are the most common mental disorders in community settings, and they are associated with significant psychological distress, functional and social impairment. Although pharmacological and psychological treatments for anxiety and depression have existed for several years now, only a minority of anxiety disorder sufferers are treated according to guidelines. Cognitive behavior therapy (CBT) is the most consistently efficacious psychological treatment for anxiety disorders, but implementation of CBT in primary care is challenging due to limited resources. Recent studies indicate that transdiagnostic group CBT for multiple anxiety disorders could be a promising alternative to individual CBT in primary care. The aim of the study is to examine the effectiveness of group CBT for anxiety disorders as a complement to usual care. The clinical trial will be conducted in three Health and Social Services Centers in the province of Québec (i.e. Sherbrooke, Laval and Québec). Patients will be French-speaking adults with anxiety disorders, and they will be randomly assigned to one of two treatment conditions: a) Transdiagnostic group CBT (12 weekly 2-hour sessions), b) usual care. The transdiagnostic group CBT will be offered as a differed intervention to participants in the usual care group after the 8-month follow up. Participants in both study arms will undergo a baseline clinical evaluation as well as outcome assessment interviews at post-treatment, 4, 8, and 12 month follow-up time-points. The primary study results will include improvement on a questionnaire on anxiety symptoms. Widespread implementation of group CBT could lead to better outcomes for a large number of patients living with anxiety.

NCT ID: NCT02810171 Completed - Anxiety Clinical Trials

Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety

Anxiety-CBT
Start date: December 2016
Phase: N/A
Study type: Interventional

Anxiety is among the most prevalent, costly and disabling illnesses and tends emerge early in childhood. Cognitive behavioral therapy (CBT) is the first-line treatment for early life anxiety, but as many as 40% of young patients who receive CBT fail to get better. The proposed study will examine brain changes marking positive response to CBT for anxiety and how these changes may differ in children compared adolescents. By helping us to understand how CBT works, this study will pave the way for new treatments to stop anxiety early.